Metraipolis › archive › dc_1ee43622afa0

Digital twin technologies in prostate cancer as a frontier for precision medicine — Europe PMC PMID:42319650

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/42319650
DOI
10.1186/s41747-[numero omesso]-8
License (as archived)
solo-consultazione
Archived
2026-10-06T10:47:58.542Z
SHA-256 of the archived text
a8ba2127848b153810961b1dcdaf0a5f356fa5b723edf930188b87983686546b
Stable URL of this page
https://metraipolis.com/documento/dc_1ee43622afa0

How to cite

Digital twin technologies in prostate cancer as a frontier for precision medicine — Europe PMC PMID:42319650 — Europe PMC (en), https://europepmc.org/article/MED/42319650 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_1ee43622afa0 (Metraipolis archive dc_1ee43622afa0, sha256 a8ba2127848b153810961b1dcdaf0a5f356fa5b723edf930188b87983686546b)
BibTeX
@misc{dc1ee43622afa0,
  title = {Digital twin technologies in prostate cancer as a frontier for precision medicine — Europe PMC PMID:42319650},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/42319650},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_1ee43622afa0; sha256 a8ba2127848b153810961b1dcdaf0a5f356fa5b723edf930188b87983686546b},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/42319650. Agents can read the archived copy with the MCP tool read_document.